Thus, the expression of sclerostin in jck mouse, a model of progressive kidney disease occurs at early stages of CKD, even before PTH and FGF-23 increase [57], suggesting that sclerostin may play an early role in the development of renal osteodystrophy. This evidence concerns the gene FGF23 and chronic kidney disease.